secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIPELLA PHARMACEUTICALS INC. (LIPO)
CIK:        0001347242
Form:       8-K
Filed at:   2024-03-15T23:59:59+00:00
Accession:  0001753926-24-000545
Event type: other_material
Sentiment:  positive
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO and CMO each purchase $100k of Lipella common stock at $0.6901/share
------------------------------------------------------------------------

- CEO Jonathan Kaufman bought 144,906 shares for $100,000 at $0.6901/share on March 12, 2024.
- CMO Michael Chancellor bought 144,906 shares for $100,000 at same price and date.
- Total insider investment of $200,000; shares subject to six-month restricted period.
- Proceeds provide working capital; shares issued directly from company treasury.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1347242/000175392624000545/0001753926-24-000545-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1347242/000175392624000545/g084127_8k.htm
  HTML page:      https://secwatch.observer/filing/0001753926-24-000545

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer